HOME >> BIOLOGY >> NEWS
Big fish not always best, sounds might mean hurricanes and Hawaii tsunami safety

  • Sea Grant Research News: Catching "Biggest" Fish May Not Be Best- Evolutionary Change May Be Impacted
  • Acoustic Sensing Methods May Improve Hurricane Prediction
  • Tsunami Forecasting Protects Hawaiian Residents, Islands
  • Sea Grant Calendar Spot Light: State-of-Maine's Beaches Conference, July 15, 2002, Saco, Maine
  • Sea Grant Website Spot Light: The Next Big Earthquake (in Alaska)

CATCHING "BIGGEST" FISH MAY NOT BE BEST - EVOLUTIONARY CHANGE MAY BE IMPACTED

Catching only the largest fish may be causing the average size of fish to decrease is the conclusion of a New York Sea Grant funded study appearing in the July 5th issue of the journal Science. Researchers David O.Conover and Stephan B. Munch posit that fishery management plans ignore evolutionary change in harvestable commercially important fisheries. They observed that in an experimental population of Atlantic silverside fish where large individuals were selectively removed, the average size of the silversides declined dramatically in just four generations. Conversely, when smaller fish were removed, the average size increased. Conover makes two suggestions to manage fisheries for sustainable harvest over the long haul: 1) A rethinking of the reliance of minimum-size restrictions as a basic management tool; 2) the establishment of no-take reserves or marine protected areas that may, if properly designed, provide for the maintenance of natural genetic variation of marine life.

CONTACT: David Conover, New York Sea Grant Researcher, Professor of Marine Science, Stony Brook University, (O) 631-632-8667, E-mail: dconover@notes.cc.sunysb.edu

ACOUSTIC SENSING METHODS MAY IMPROVE HURRICANE PREDICTION

False hurricane evacuations can cost coastal areas millions of dollars. Yet warnings that do not come in time can cost lives. Evacuation inaccuracies occur be
'"/>

Contact: Ben Sherman
sherman@nasw.org
202-662-7095
National Sea Grant College Program
8-Jul-2002


Page: 1 2 3 4

Related biology news :

1. Once a renin cell, always a renin cell
2. Bigger isnt always better--especially if youre a rodent
3. Dont always believe what you see, suggests study on false memories
4. Born shy, always shy? Temperamental differences may last throughout life, brain study suggests
5. Fish is not always brain food
6. One fig, one wasp? Not always!
7. Research shows less income, education not always top factors in child obesity
8. Increasing biodiversity is not always best
9. Men are faster than women. but does that mean bets should always be placed on colts?
10. Brain damage in infants not always tied to delivery
11. Plant stems and leaves are always proportional to roots

Post Your Comments:
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ) has ... Market by Application, Technology, Function & Geography - Global ... The next generation biometrics market is expected to ... 17.9% between 2015 and 2020 Travel & ... Safran SA ( France ), NEC ...
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/25/2015)... , June 25, 2015 ... Market by Type (Swipe & Area), Technology, Material (Optical ... Healthcare, Commercial Security & Others) & Geography - ... marketsandmarkets, the said market is expected to reach ... 17.1%. Browse 76 market Tables ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
(Date:7/30/2015)... Denmark , July 30, 2015 ... biotechnology company that applies its innovative TransCon technology ... positive top-line results from a six-month Phase 2 ... once-weekly TransCon Growth Hormone in 53 treatment-naïve, pre-pubertal ... "We are extremely pleased with the top-line ...
(Date:7/30/2015)... , ... July 30, 2015 , ... As part of its 2015 growth plan and ... and technical service business units, Whitehouse Laboratories is pleased to announce that it ... to the Container Center of Excellence and will be strictly dedicated to basic USP 51, ...
(Date:7/29/2015)... , July 30, 2015 ... la santé, publie ses résultats pour le premier ... commente les résultats. Visionner l,interview ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Au sommaire de ... - Moteurs de croissance - ...
(Date:7/29/2015)... (Q2 2015: +14% CER / 20% of sales) led the regional performance in ... , as well as solid contributions from Korea, India ... Middle East / Africa (Q2 2015: ... , Turkey and the United Kingdom ... excluding U.S. HPV sales, on demand across all customer classes. The top seven ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10
Cached News: